(1)
Hansen, C. R.; Bertelsen, A. S.; Hazell, I.; Stougaard, S. W.; Johansen, J.; Overgaard, J.; Eriksen, J. G.; Zukauskaite, R. Eliminating the High-Risk CTV1 Margin in DAHANCA Oropharyngeal Radiotherapy: Dosimetric Impact on Dysphagia and Organ-at-Risk Doses. AO 2025, 64, 1205-1211.